JG
NVO

Joel Greenblatt’s Novo Nordisk NVO Stock Holding History

Joel Greenblatt’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$228K Buy
+4,758
New +$204K ﹤0.01% 1712
2026
Q1 		– Sell
-3,987
Closed -$203K – 1831
2025
Q4 		$203K Buy
+3,987
New +$204K ﹤0.01% 1652

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Joel Greenblatt's NVO Position: Q2 2026 in Review

Joel Greenblatt opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,758 shares worth $228K. The stake represents ﹤0.01% of the portfolio and ranks #1712 among its holdings. This is a return to the name: Joel Greenblatt previously reported a position in NVO as recently as Q4 2025.

Joel Greenblatt first reported a position in NVO in Q4 2025 and has held it in 2 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Joel Greenblatt held 4,758 shares of Novo Nordisk worth $228K as of Q2 2026.
  • Novo Nordisk was a new Joel Greenblatt position in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of Joel Greenblatt's portfolio in Q2 2026, its #1712 holding.
  • Joel Greenblatt first reported a position in Novo Nordisk in Q4 2025 and has held it in 2 quarters since.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.